Prostate specific antigen levels during radical radiation therapy and the prediction of outcome in localized carcinoma of the prostate
- 1 January 1997
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 9 (4) , 226-233
- https://doi.org/10.1016/s0936-6555(97)80006-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implicationsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment OutcomeJournal of Urology, 1994
- The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: an early indicator of response to treatmentRadiotherapy and Oncology, 1994
- Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling timeInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, 1993
- Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapyRadiotherapy and Oncology, 1992
- Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation TherapyJournal of Urology, 1991
- Prostate Specific Antigen after Irradiation for Prostatic CarcinomaJournal of Urology, 1990
- A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1990